Table of Content

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Clinical Trial Analysis
5.1. Ongoing Clinical Trials
5.2. Completed Clinical Trials
5.3. Terminated Clinical Trials
5.4. Breakdown of Pipeline, By Development Phase
5.5. Breakdown of Pipeline, By Status
5.6. Breakdown of Pipeline, By Study Application
5.7. Breakdown of Pipeline, By Region
5.8. Clinical Trials Heat Map
6. Global Exosome Therapeutics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Exosome Type (Natural v/s Hybrid)
6.2.2. By Source (Mesenchymal Stem Cells, Blood, Body Fluids, Others)
6.2.3. By Therapy (Immunotherapy, Chemotherapy, Gene Therapy)
6.2.4. By Application (Metabolic Disorders, Oncology, Cardiac Disorders, Neurology, Others)
6.2.5. By End User (Hospitals & Clinics, Academic & Research Institutions, Others)
6.2.6. By Company (2022)
6.2.7. By Region
6.3. Market Map
7. North America Exosome Therapeutics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Exosome Type
7.2.2. By Source
7.2.3. By Therapy
7.2.4. By Application
7.2.5. By End User
7.2.6. By Country
7.3. North America: Country Analysis
7.3.1. United States Exosome Therapeutics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Exosome Type
7.3.1.2.2. By Source
7.3.1.2.3. By Therapy
7.3.1.2.4. By Application
7.3.1.2.5. By End User
7.3.2. Mexico Exosome Therapeutics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Exosome Type
7.3.2.2.2. By Source
7.3.2.2.3. By Therapy
7.3.2.2.4. By Application
7.3.2.2.5. By End User
7.3.3. Canada Exosome Therapeutics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Exosome Type
7.3.3.2.2. By Source
7.3.3.2.3. By Therapy
7.3.3.2.4. By Application
7.3.3.2.5. By End User
8. Europe Exosome Therapeutics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Exosome Type
8.2.2. By Source
8.2.3. By Therapy
8.2.4. By Application
8.2.5. By End User
8.2.6. By Country
8.3. Europe: Country Analysis
8.3.1. France Exosome Therapeutics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Exosome Type
8.3.1.2.2. By Source
8.3.1.2.3. By Therapy
8.3.1.2.4. By Application
8.3.1.2.5. By End User
8.3.2. Germany Exosome Therapeutics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Exosome Type
8.3.2.2.2. By Source
8.3.2.2.3. By Therapy
8.3.2.2.4. By Application
8.3.2.2.5. By End User
8.3.3. United Kingdom Exosome Therapeutics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Exosome Type
8.3.3.2.2. By Source
8.3.3.2.3. By Therapy
8.3.3.2.4. By Application
8.3.3.2.5. By End User
8.3.4. Italy Exosome Therapeutics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Exosome Type
8.3.4.2.2. By Source
8.3.4.2.3. By Therapy
8.3.4.2.4. By Application
8.3.4.2.5. By End User
8.3.5. Spain Exosome Therapeutics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Exosome Type
8.3.5.2.2. By Source
8.3.5.2.3. By Therapy
8.3.5.2.4. By Application
8.3.5.2.5. By End User
9. Asia-Pacific Exosome Therapeutics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Exosome Type
9.2.2. By Source
9.2.3. By Therapy
9.2.4. By Application
9.2.5. By End User
9.2.6. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. China Exosome Therapeutics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Exosome Type
9.3.1.2.2. By Source
9.3.1.2.3. By Therapy
9.3.1.2.4. By Application
9.3.1.2.5. By End User
9.3.2. India Exosome Therapeutics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Exosome Type
9.3.2.2.2. By Source
9.3.2.2.3. By Therapy
9.3.2.2.4. By Application
9.3.2.2.5. By End User
9.3.3. Japan Exosome Therapeutics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Exosome Type
9.3.3.2.2. By Source
9.3.3.2.3. By Therapy
9.3.3.2.4. By Application
9.3.3.2.5. By End User
9.3.4. South Korea Exosome Therapeutics Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Exosome Type
9.3.4.2.2. By Source
9.3.4.2.3. By Therapy
9.3.4.2.4. By Application
9.3.4.2.5. By End User
9.3.5. Australia Exosome Therapeutics Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Exosome Type
9.3.5.2.2. By Source
9.3.5.2.3. By Therapy
9.3.5.2.4. By Application
9.3.5.2.5. By End User
10. South America Exosome Therapeutics Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Exosome Type
10.2.2. By Source
10.2.3. By Therapy
10.2.4. By Application
10.2.5. By End User
10.2.6. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Exosome Therapeutics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Exosome Type
10.3.1.2.2. By Source
10.3.1.2.3. By Therapy
10.3.1.2.4. By Application
10.3.1.2.5. By End User
10.3.2. Argentina Exosome Therapeutics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Exosome Type
10.3.2.2.2. By Source
10.3.2.2.3. By Therapy
10.3.2.2.4. By Application
10.3.2.2.5. By End User
10.3.3. Colombia Exosome Therapeutics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Exosome Type
10.3.3.2.2. By Source
10.3.3.2.3. By Therapy
10.3.3.2.4. By Application
10.3.3.2.5. By End User
11. Middle East and Africa Exosome Therapeutics Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Exosome Type
11.2.2. By Source
11.2.3. By Therapy
11.2.4. By Application
11.2.5. By End User
11.2.6. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Exosome Therapeutics Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Exosome Type
11.3.1.2.2. By Source
11.3.1.2.3. By Therapy
11.3.1.2.4. By Application
11.3.1.2.5. By End User
11.3.2. Saudi Arabia Exosome Therapeutics Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Exosome Type
11.3.2.2.2. By Source
11.3.2.2.3. By Therapy
11.3.2.2.4. By Application
11.3.2.2.5. By End User
11.3.3. UAE Exosome Therapeutics Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Exosome Type
11.3.3.2.2. By Source
11.3.3.2.3. By Therapy
11.3.3.2.4. By Application
11.3.3.2.5. By End User
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
13.1. Recent Developments
13.2. Mergers & Acquisitions
13.3. Product Launches
14. Competitive Landscape
14.1. Business Overview
14.2. Company Snapshot
14.3. Products & Services
14.4. Financials (As reported)
14.5. Recent Developments
14.6. SWOT Analysis
14.6.1. Aethlon Medical, Inc.-Exosome Sciences
14.6.2. Aegle Therapeutics
14.6.3. Anjarium Biosciences AG
14.6.4. Exogenus Therapeutics SA
14.6.5. Lonza Group
14.6.6. Capricor Therapeutics, Inc.
14.6.7. Avalon Globocare Corp
14.6.8. Stem Cell Medicine Ltd.
14.6.9. Evox Therapeutics Limited
14.6.10. EV Therapeutics
15. Strategic Recommendations